Skip to content

Exploratory Clinical Study on Microprotein MP278 for Auxiliary Diagnosis of Colorectal Cancer

Exploratory Clinical Study on Microprotein MP278 for Auxiliary Diagnosis of Colorectal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117571
Enrollment
Unknown
Registered
2026-01-26
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. For healthy volunteers: (1) Age 18-70 years; (2) Underwent a medical examination within the past 5 years, excluding colorectal cancer and precancerous lesions; (3) No family history of colorectal cancer; (4) Voluntarily willing to participate in this clinical study. 2. For colorectal cancer patients: (1) Age 18-70 years; (2) Pathological biopsy before or after surgery confirming a diagnosis of colorectal adenocarcinoma; (3) Clinical stage I-IV, undergoing radical resection surgery; (4) Voluntarily willing to participate in this clinical study.

Exclusion criteria

Exclusion criteria: 1. Receive neoadjuvant therapy, including chemotherapy, radiotherapy, immunotherapy, and other treatments; 2. Individuals with liver or kidney dysfunction; 3. Presence of metastases that cannot be surgically removed or non-R0 resection; 4. Patients lost to follow-up after surgery.

Design outcomes

Primary

MeasureTime frame
MP278 concentration;

Countries

China

Contacts

Public ContactChangzheng Du

Beijing Tsinghua Changgung Hospital

dzza04606@btch.edu.cn+86 182 0167 3524

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026